logo
Dunbar School Foundation owes state $460K for unallowable DSF Stop vaccine program spending

Dunbar School Foundation owes state $460K for unallowable DSF Stop vaccine program spending

Yahoo16-03-2025
Mar. 16—dbeard @dominionpost.com MORGANTOWN — The Dunbar School Foundation must refund $460, 362.96 to the state Department of Health for unallowable expenses associated with the DSF Stop COVID-19 vaccine program.
The refund represents 42 % of the Stop program's $1, 100, 649.60 taxpayer-funded grant provided through the state Office of Epidemiology and Prevention Services for the period of April 1, 2021 through June 30, 2022, according to the report provided to The Dominion Post.
The 107-page "Findings and Technical Assistance Report " spells out the unallowable expenses in detail.
They include $262, 048.05 for personnel questioned costs ; $32, 171.86 for personnel miscalculated expenditures ; $12, 222.27 for unallowable cell phone costs ; $25, 240.78 for unallowable vaccine outreach costs ; $12, 484.22 for unallowable event supplies ; $17, 353.32 for unallowable building rent ; $44, 051.65 for unallowable marketing costs ; $17, 043.51 for contractual costs with "very weak supporting documentation "; and $11, 974.94 for unallowable technical device and software costs."
The Dominion Post ran a series of stories on allegations of misspending by DSF Stop program leaders starting in May 2023, following months of research that began in fall 2022.
We learned at the time that DSF Stop was already under review by what was the Department of Health and Human Resources. DSF Stop ceased operations in June 2023 and abandoned its headquarters building near downtown Fairmont, across the street from the former Dunbar High School.
We reported last October that DSF Stop was under investigation by the U.S. Department of Justice for potential misuse of public funds. The foundation and former DSF Stop CEO Romelia Hodges were ordered to provide an array of documents to the DOJ by U.S. Magistrate Judge Michael Aloi.
DOJ investigators cited reporting by The Dominion Post in their case, saying its investigation "indicates that Dunbar Stop may have misused the grant funds for nepotism, excessive executive salaries and bonuses, ATM withdrawals, luxury vehicle rentals, travel, and food."
DSF Stop was created to serve the African-American population in Marion and surrounding counties and funded through federal COVID funds channeled through the former DHHR. Stop received two grants to conduct its operations. Its initial grant budget for the period April 1, 2021 through June 30, 2022 was $1, 197, 421 (different from the number in the report). A second grant, for July 1, 2022 through May 31, 2023, was for $990, 000.
The report is dated Jan. 17, 2024 but was only released to The Dominion Post earlier this months after two Freedom of Information Act requests and regular contacts throughout 2023 and 2024.
Hodges could not be reached by phone for comment on the report, and did not respond to three requests sent by email which included questions about how the money would be repaid. The Dominion Post also reached out to the Department of Health with questions about repayment of the funds. Other than asking for our deadline following the first email, DH did not respond to three subsequent reminders.
Former Dunbar School Foundation President Houston Richardson was one who alerted The Dominion Post of concersn in late 2022 ; he raised questions about potential misspending of public funds, nepotism and lack of accountability.
Regarding the report, he said on Wednesday, "If the information reported is factual, I find it to be very sad for the public and especially the black community. This program was started to help inoculate our citizens against the COVID virus and we (Dunbar School Foundation) all felt that the program as presented would save lives."
A look at the numbers The report sifts through unallowable spending line by line. We can look at a few highlights here.
On the $262, 048.05 for personnel questioned costs, it notes missing certifications or timesheets for various personnel across five reporting quarters.
Questioned costs for Hodges totaled $162, 000. Questioned costs for Chief Operating Office Tiffany Samuels totaled $42, 500. And questioned costs for Stop's medical supervisor totaled $22, 600.14.
The report consistently critiques the program's financial management and internal controls. Often noting relatively small amounts.
For instance, on four occasions, Stop bought snacks totaling $377.87 for vaccination events. The report notres that Bureau for Public Health staff twice told Stop that food is not an allowable purchase: Stop never requested food in its budget and it was never approved.
And 13 unallowable fuel purchases totaling $577.37, including at gas stations in Maryland, Virginia, Ohio and Pennsylvania were charged. DH said the purchases were made outside Stop's program area. Another $204.30 for fuel was charged after the grant period.
For the $12, 222.77 in unallowable cell phone costs, Stop could not provide invoices with the customer, employee and usage information. In two instances, the only documentation was debt settlement letters.
The report records five instances of unallowable vehicle rentals for personal use, totaling $2, 000.32 ; turnpike tolls for personal use totaling $40.30 ; and $1, 922.23 in state sales taxes on vehicle rentals.
For the June 2022 Juneteenth vaccination event, Stop billed $948.71 ofr travel expenses: $476.09 for Hodges to pick up a speaker in New Jersey, and $472.62 for hotel stays for three people.
The $25, 240.78 for unallowable vaccine outreach costs included $21, 988.98 for unallowable entertainment costs, such as a bounce house, yard signs and banners, a 45-foot paratrooper drop, a rapid slide, "Tubs of Fun " and a rock wall ; plus $948.75 for food.
The report says of this portion, "The disallowed costs represent 90.6 % of the total vaccine outrach costs that were charged to the grant."
And the $12, 484.22 for unallowable event supplies represented 48.6 % of the event supplies costs charged to the grant. Among them was a $3, 350 cash withdrawal paid to Hodges for "unallowed ... unnecessary and unreasonable expenses for the federal award."
We reported on the building rent issue in June 2023, noting at the time that Stop was $11, 000 in arrears for rental of the former Dunbar school cafeteria that Stop remodeled for its headquarters. The last rent check was received in November 2022.
Hodges at the time acknowledged the delinquency and said that as part of the DHHR review, the state said DSF and Stop did not have an arm's length lease agreement ; the state views them as one organization and wouldn't allow it to pay itself rent. So they had to modify that line item in their budget and were waiting to hear back from the state.
The lease set rental payments at $6, 250 per month. In the report, DH said four lease payments of $4, 338.33, totaling $17, 353.32, were unallowable because "less-than-arm's-length " agreements are only allowed up to a set figure for depreciation, maintenance, taxes and insurance. The foundation was responsible to cover those four items. The remainder — the $4, 338.33 per month — was not a qualified expense.
The unallowable marketing costs totaled $44, 051.65. That included $23, 333.36 to the owner of Jamgood Juicery, a Cincinnati, Ohio, mobile juice bar. Hodges contract with the owner, Jennifer Troutman, for $40, 000 per year for marketing, branding, event promotion and other duties.
IN May 2023, Jamgood was filed as a business with the Ohio secretary of state, its Instagram page had been taken down. Troutman had attempted a failed Kickstarter campaign in 2018, raising only $1 of its $6, 800 goal to buy a juice truck. The plan was a "mobile Juice and Smoothie Bar catering to youth athletics and sports programs, focused on true wellness and nutritional awareness."
She wrote at the time, "I'm a newbie to the mobile juice industry but have extensive experience in marketing /public relations that will serve me well when building an audience that matters !" In 2023, she was assistant director of Student Engagement & Diversity in the Farmer School of Business at Miami University in Oxford, Ohio.
Other unallowable marketing expenses included $7, 500 for a Ferris wheel and $6, 000 for Zoogang Touring, termed by Stop as an "influential marketer."
The report details extensively what advertising and public relations costs are allowed and which are not. The section concludes with, "Grantee should improve internal controls to ensure that expenditures are utilized for programmatic purposes."
Conflict of interest We conclude with an item in the final section of the report, devoted to technical assistance. Under the heading "Conflict of Interest, " the report says Hodges and Samuels awarded themselves bonuses of $12, 000 and $7, 500 respectively.
(In May 2023 we reported that in December 2021, 10 Stop employees each received $200 bonuses. Hodges and Samuels at that time awarded themselves $5, 000 bonuses.)
In 2022, DHHR asked about this issue, and if DSF Stop had a board of directors that approved these payouts. We reported at the time, using Aug. 23, 2021, foundation minutes, that "Romelia and Tiffany requested the board to approve Executive Privileges within the grant. This will allow them the authority to make decisions on employees, compensation, bonuses, and other items that are allowable within the confines of the grant."
That was moved, seconded and approved.
Former foundation President Houston Richardson told The Dominion Post at the time that the board lacked the expertise to establish and oversee a COVID program. He regretted that he realized too late they should should have set up an independent oversight committee to oversee all aspects of Stop's operations.
The report notes that policy requirements on conflict of interest say, "The Grantee will establish procedures to prohibit employees from using their positions for a purpose that constitutes or presents the appearance of personal gain."
The report cites the minutes indicating that the foundation board approved the bonus pay structure.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US ESG Market Is Dominated by Foreign Companies More Than Ever
US ESG Market Is Dominated by Foreign Companies More Than Ever

Bloomberg

time7 minutes ago

  • Bloomberg

US ESG Market Is Dominated by Foreign Companies More Than Ever

The US market for sustainable bonds is being crowded by foreign companies this year more than ever, as political backlash and negligible pricing benefits continue to keep American companies on the sidelines. Foreign firms account for 89% of green, social, sustainability and sustainability-linked corporate-securities sales in dollars this year, up from 76% through the first half of last year and just 30% in 2020, BloombergNEF data through the end of June shows.

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win
Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

Yahoo

time7 minutes ago

  • Yahoo

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

LONDON (Reuters) -Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in the latest round of a long-running legal dispute between the two sides. A year ago, the High Court ruled that one of Moderna's two patents relating to the messenger RNA (mRNA) technology that underpinned its COVID-19 vaccine was valid and that Pfizer and BioNTech's Comirnaty vaccine had infringed it, meaning Moderna is entitled to damages in relation to sales after March 2022. The court also ruled last July that the other Moderna patent under challenge in the case was invalid. Pfizer and Moderna are seeking to overturn the decision that one of the patents is valid, after Judge Richard Meade gave the two companies permission to appeal against his decision. They argue Moderna's developments of mRNA technology were obvious developments of previous work, rendering the patent invalid, though Moderna says the judge's ruling should be upheld. Pfizer and BioNTech generated more than $3.3 billion in revenue from global sales of their vaccine Comirnaty last year, while Moderna generated $3.2 billion from its vaccine Spikevax, according to company reports. Sales of both vaccines declined significantly between 2023 and 2024 after the pandemic ended. Pfizer and BioNTech had sued Moderna in London in September 2022, seeking to revoke the two patents held by Moderna, which hit back days later alleging its own patents had been infringed. The London lawsuits are just one part of a global battle between Pfizer, BioNTech and Moderna over their competing vaccines, which helped save millions of lives during the pandemic. The companies have also been involved in proceedings in Germany – where a court ruled in Moderna's favour in March – the United States Patent Office, which held that two Moderna COVID-19 vaccine patents were invalid, and elsewhere.

Up Nearly 20% in a Month, Is This Turnaround Dividend Stock Still a Buy in July?
Up Nearly 20% in a Month, Is This Turnaround Dividend Stock Still a Buy in July?

Yahoo

time10 minutes ago

  • Yahoo

Up Nearly 20% in a Month, Is This Turnaround Dividend Stock Still a Buy in July?

Usually, corporate dividends and high dividends don't make a good combo, as one of the ways companies try to 'turn around' their business is by cutting costs, and at times, this means cutting dividends as they try to lower their cash outflows. Additionally, the reason the company needs to 'turn around' in the first place is that it is not performing well financially, which implies that the dividend might be at risk of being cut or suspended altogether. 2 ETFs Offering Juicy Dividend Yields of 20% or Higher Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. However, I believe Nike is one stock that fits into the category of a turnaround dividend stock. The stock has a dividend yield of over 2%, and while that has come down from the 2025 highs amid the nearly 20% rise in NKE shares over the last month, it still looks like a buy. Let's discuss this in perspective, starting with the company's dividend. While some companies have a well-documented dividend policy, Nike does not have a stated policy on payouts. However, it has increased its dividends for 23 consecutive years and appears to be on track to become a Dividend Aristocrat. The company increased its dividends even during the 2008 Global Financial Crisis and the COVID-19 pandemic in 2020. Despite its earnings taking a blow in recent quarters, the company increased its quarterly dividend by 8% to $0.40 in December 2024. The dividends have grown at a compound annual growth rate (CAGR) of 10.3% over the last five years, while the CAGR for the past 10 years is slightly above 11%. That looks like pretty decent growth, and I have no reason to believe that the company will cut its dividend anytime soon. Nike's current dividend yield is around 2.1%, which, while not mouthwatering, is well ahead of the 1.3% that an average S&P 500 Index ($SPX) constituent pays. Meanwhile, while Nike has a healthy dividend yield, the payout should not be the only reason for buying the stock, as it's the bulk of its returns doesn't come from dividends. Nike investors should expect the bulk of their returns from capital appreciation, so it is prudent to look at the stock's forecast. While multiple brokerages, including Goldman Sachs, Piper Sandler, Citigroup, HSBC, Barclays, and Baird, raised Nike's target price following the company's fiscal Q4 2025 earnings last month, the stock trades at almost the mean target price of $76.63. However, the Street-high target price of $120 is 56.8% higher than the July 7 closing price. The stock has a consensus rating of 'Moderate Buy' from the 36 analysts covering the stock, but over the last two weeks, it has earned upgrades from HSBC and Argus. Nike is an iconic brand. However, it has lost some of its sheen due to its relative lack of innovation. Moreover, the company lost out to established brands like Adidas (ADDYY), as well as newer brands like New Balance, Hoka (DECK), and On Running (ONON), as the decision to cut down on wholesale sales backfired and only helped competitors gain shelf space, which eventually ensured a higher share of customer wallets. Nike is reversing some of its policies and has now doubled down on third-party sellers. It has also started selling on Amazon (AMZN) after quitting the e-commerce platform in 2019. Here, it is worth noting that Nike pivoted away from third-party sellers for a reason. Having its own channels gives the company more control and helps better connect with customers. Moreover, the pivot helped Nike expand its gross margins. However, soon enough, the strategy took a toll on Nike's sales as its products were not stocked by many third-party sellers. As Nike starts focusing on third-party sellers, it might not be able to enjoy the kind of margins it did at its peak in early 2022. However, the company now has a two-pronged strategy where it intends to use its direct channel for premium products, which will be higher-margin. The company's turnaround is showing results, and it should soon return to top-line growth with stable margins. Turnaround-related costs have been a headwind for the last couple of quarters, but during the fiscal Q4 2025 earnings call, CFO Matt Friend said that the quarter 'reflected the largest financial impact' from its Win Now turnaround plan. The company expects the pressure on the top line and margins to start moderating, but sees another 75-basis point of margin impact this fiscal year. China, meanwhile, remains a structural headwind for Nike as not only is that market not growing as fast as it once used to, but Chinese consumers have increasingly been preferring domestic brands against U.S. rivals. All said, I believe Nike's turnaround is progressing in the right direction, and the stock might fit into portfolios of dividend investors who crave a mix of both dividend growth and capital appreciation over the medium to long term. On the date of publication, Mohit Oberoi had a position in: NKE, AMZN. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store